Literature DB >> 15249791

Obesity and high blood pressure: a clinical phenotype for the insulin resistance syndrome in African Americans.

Kimberly L Campbell1, Harvey Kushner, Bonita Falkner.   

Abstract

The high prevalence of insulin resistance syndrome in African Americans predisposes this population to higher morbidity and mortality from cardiovascular disease. To test the hypothesis that the combination of obesity and high blood pressure (BP) represents the physical phenotype of insulin resistance syndrome, 337 African-American men and women aged 32+/-4 years were examined and classified into four groups (nonobese-normal BP, nonobese-high BP, obese-normal BP, obese-high BP), according to presence or absence of obesity and high BP. Mean values of glucose, insulin, lipids, urinary albumin excretion, and clamp-derived insulin sensitivity were determined for each group. Prevalence of prediabetes (24.4%), diabetes (19.2%), and insulin resistance syndrome (87.2%) were highest in the obese-high BP group (p<0.001). Mean triglycerides, urinary albumin excretion, fasting glucose, fasting insulin, and insulin resistance were highest in the obese-high BP group (p<0.001). Subjects with both obesity and high BP showed greater expression of lipid and glucose abnormalities, higher urinary albumin excretion, and greater prevalence of prediabetes, undetected type 2 diabetes, and insulin resistance syndrome.

Entities:  

Mesh:

Year:  2004        PMID: 15249791      PMCID: PMC8109354          DOI: 10.1111/j.1524-6175.2004.03536.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  25 in total

1.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

2.  Cardiovascular morbidity and mortality associated with the metabolic syndrome.

Authors:  B Isomaa; P Almgren; T Tuomi; B Forsén; K Lahti; M Nissén; M R Taskinen; L Groop
Journal:  Diabetes Care       Date:  2001-04       Impact factor: 19.112

3.  Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey.

Authors:  Earl S Ford; Wayne H Giles; William H Dietz
Journal:  JAMA       Date:  2002-01-16       Impact factor: 56.272

4.  Racial differences in risk factors for atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities.

Authors:  R G Hutchinson; R L Watson; C E Davis; R Barnes; S Brown; F Romm; J M Spencer; H A Tyroler; K Wu
Journal:  Angiology       Date:  1997-04       Impact factor: 3.619

5.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

6.  High-density-lipoprotein cholesterol in heparin-MnCl2 supernates determined with the Dow enzymic method after precipitation of Mn2+ with HCO3-.

Authors:  P S Bachorik; R E Walker; D G Virgil
Journal:  Clin Chem       Date:  1984-06       Impact factor: 8.327

Review 7.  The Metabolic Syndrome in African Americans: a review.

Authors:  W Dallas Hall; Luther T Clark; Nanette K Wenger; Jackson T Wright; Shiriki K Kumanyika; Karol Watson; Ella W Horton; John M Flack; Keith C Ferdinand; James R Gavin; James W Reed; Elijah Saunders; Welton O'Neal
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

8.  Factor analysis and defining the metabolic syndrome.

Authors:  Earl S Ford
Journal:  Ethn Dis       Date:  2003       Impact factor: 1.847

9.  Prevalence and trends in obesity among US adults, 1999-2000.

Authors:  Katherine M Flegal; Margaret D Carroll; Cynthia L Ogden; Clifford L Johnson
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

10.  Clinical significance of cardiovascular dysmetabolic syndrome.

Authors:  Prakash C Deedwania
Journal:  Curr Control Trials Cardiovasc Med       Date:  2002-01-07
View more
  4 in total

1.  Simultaneous renal hypertension and type 2 diabetes exacerbate vascular endothelial dysfunction in rats.

Authors:  Azadeh Khalili; Ali Akbar Nekooeian; Mohammad Bagher Khosravi; Shima Fakher
Journal:  Int J Exp Pathol       Date:  2012-03-28       Impact factor: 1.925

Review 2.  Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States.

Authors:  Bonita Falkner; Nicole D F H Cossrow
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

3.  Adiponectin regulates albuminuria and podocyte function in mice.

Authors:  Kumar Sharma; Satish Ramachandrarao; Gang Qiu; Hitomi Kataoka Usui; Yanqing Zhu; Stephen R Dunn; Raogo Ouedraogo; Kelly Hough; Peter McCue; Lawrence Chan; Bonita Falkner; Barry J Goldstein
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

4.  Association between Frequency of Toothbrushing and Metabolic Syndrome among Adolescents: A 5-Year Follow-Up Study.

Authors:  Jagan Kumar Baskaradoss; Mary Tavares; Fahd Al-Mulla; Ebaa Al-Ozairi; Mohamed Abu-Farha; Saadoun Bin-Hasan; Aishah Alsumait; Sriraman Devarajan; Hend Alqaderi
Journal:  Int J Environ Res Public Health       Date:  2022-01-03       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.